Submit ticket request  // Limit: 1 // Tickets Available: 1

 Each invited institution may only submit one application to the program which meets the eligibility requirements for the 2025 Grant Cycle. Applicants must be full-time faculty at an invited non-profit academic, medical, non-governmental or research institutions. United States citizenship is not required. Junior faculty are encouraged to apply. 

Apply to the UA internal competition  // Limit: 1 // Tickets Available: 1 

*UA may submit one proposal under the Research Partnerships track. There is no institutional limitation on the Technology Translation track.

Limit: 1// R. Liang (Wyant College of Optical Sciences)

*UA may submit one proposal under the Research Partnerships track. There is no institutional limitation on the Technology Translation track.

Limit:1 // SF-Wung (College of Nursing)

One application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed. This FOA seeks to support programs that include innovative approaches to enhance biomedical engineering (BME) designeducation to ensure a future workforce that can meet the nation’s needs in biomedical research and healthcare technologies.

Due to a change in submission processes, the University of Arizona is currently ineligible to apply to this opportunity. 

Limit: 25 per calendar year // Tickets Available: 19

No Applicants // Limit: 1 // Tickets Available: 1 

No Applicants  // Limit: 1 // Tickets Available: 1 

The CLS Program will fund U.S. undergraduate and graduate students to study critical languages through intensive overseas language institutes organized in countries and locations where the target languages are widely spoken and through virtual programming. Anticipated languages for this component include Arabic, Chinese (Mandarin), Hindi, Indonesian, Japanese, Korean, Persian, Portuguese, Russian, Swahili, Turkish, and Urdu.

No Applicants // Limit: 1 // Tickets Available: 1 

No Applicants // Limit: 2 // Tickets Available: 2 

The PRINT program aims to transform organ biofabrication by leveraging recent advances in 3D bioprinting, cell manufacturing, biomaterials, modeling, and tissue engineering. The PRINT program will assemble the necessary tools to facilitate production from a human cell source to a patient matched biofabricated organ to restore at least 40% normal organ function as demonstrated in a large animal model. 

Areas of Interest:

No Applicants   // Limit: 1 // Tickets Available: 1